Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
08/14/2003 | WO2003066843A2 Method for the production of a nerve transplant |
08/14/2003 | WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
08/14/2003 | WO2003066839A1 Lineage committed stem cells selected for telomerase promoter activity |
08/14/2003 | WO2003066832A2 Generation of new insulin cells from progenitor cells present in adult pancreatic islets |
08/14/2003 | WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system |
08/14/2003 | WO2003066101A1 Preparation for oxidation-sensitive compounds and method for making same |
08/14/2003 | WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
08/14/2003 | WO2003066075A1 Medication for curing dysbacteriosis and the method for production thereof |
08/14/2003 | WO2003066072A2 Cell therapy using immunoregulatory t-cells |
08/14/2003 | WO2003066014A1 Use of a hsp inducing compound to limit secondary effects of retinoids |
08/14/2003 | WO2003065999A2 Proliferated cell lines and uses thereof |
08/14/2003 | WO2003065997A2 Anti-infarction molecules |
08/14/2003 | WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy |
08/14/2003 | WO2003065979A2 Methods of diagnosis, monitoring and treatment of fertility |
08/14/2003 | WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins |
08/14/2003 | WO2003065802A1 Methods for sterilizing tissue |
08/14/2003 | WO2003048183A3 Method for obtaining oestrogen from mare urine |
08/14/2003 | WO2003047617A3 Vaccine |
08/14/2003 | WO2003029433A3 Chimeric viral vectors for gene therapy |
08/14/2003 | WO2003027232A3 Method for producing biologically active products |
08/14/2003 | WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
08/14/2003 | WO2003013558A8 Treatment of radiation-induced diarrhea with probiotics |
08/14/2003 | WO2003012060A3 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
08/14/2003 | WO2003006613A3 Methods for ex vivo propagation of somatic stem cells |
08/14/2003 | WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
08/14/2003 | WO2002039116A3 Retrovirus isolated from humans |
08/14/2003 | WO2002038601A3 Foggy |
08/14/2003 | US20030153615 Novel compositions and uses of dictyostatin compounds |
08/14/2003 | US20030153518 Activation and inhibition of the immune system |
08/14/2003 | US20030153511 Administering a dose of multiple function protein 14 (MFP 14), animal extracts from liver |
08/14/2003 | US20030153491 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
08/14/2003 | US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies |
08/14/2003 | US20030153078 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
08/14/2003 | US20030153074 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
08/14/2003 | US20030153073 Expansion of T cells in vitro and expanded T cell populations |
08/14/2003 | US20030153044 Tissues or organs for use in xenotransplantation |
08/14/2003 | US20030153029 Extraction from mammals skins; culturing; therapy for asthma, antiallergens |
08/14/2003 | US20030152909 Tissue/organ models; improved storage stability; drug screening |
08/14/2003 | US20030152650 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation |
08/14/2003 | US20030152645 Aqueous ionic solutions and their uses in particular in ophthlamology |
08/14/2003 | US20030152641 Purified cytokine inhibitory factor |
08/14/2003 | US20030152640 Method and composition for treating viral outbreaks |
08/14/2003 | US20030152639 Novel wound healing composition not containing bovine-derived activating reagents |
08/14/2003 | US20030152596 Mixture of elastase inhibitor and fungicide or bactericide; antiinflammatory agent |
08/14/2003 | US20030152594 Immunology response intensifiers; administering a bacterial lysate |
08/14/2003 | US20030152586 Dietary supplements comprising growth media |
08/14/2003 | US20030152585 Herbal formulation |
08/14/2003 | US20030152569 Method for removing and reducing Hepatitis C virus |
08/14/2003 | US20030152562 Diffusion of gases, nutrients into micro-organs; culture; cell proliferation |
08/14/2003 | US20030152558 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
08/14/2003 | US20030152556 Fabrication of a cartilage implant |
08/14/2003 | US20030152553 Transfection, transduction of cells |
08/14/2003 | US20030152550 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
08/14/2003 | CA2476275A1 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate cns nerve regeneration |
08/14/2003 | CA2476214A1 Proliferated cell lines and uses thereof |
08/14/2003 | CA2475112A1 Anti-infarction molecules |
08/14/2003 | CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system |
08/14/2003 | CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
08/14/2003 | CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
08/14/2003 | CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins |
08/13/2003 | EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
08/13/2003 | EP1335019A1 T cell line and use thereof |
08/13/2003 | EP1335018A1 Sericin-containing material, process for producing the same and method of using the same |
08/13/2003 | EP1334188A2 Cd19-specific redirected immune cells |
08/13/2003 | EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
08/13/2003 | EP1334177A1 Generation and use of dendritic cells |
08/13/2003 | EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
08/13/2003 | EP1334135A2 Resin based on polystyrene functionalised by methyl ester groups of l-tyrosine and their uses |
08/13/2003 | EP1334126A1 Human stra6-like protein and nucleic acids encoding the same |
08/13/2003 | EP1333863A2 Vector system for transducing th positive neurons |
08/13/2003 | EP1333847A1 Combination preparation of a biological response modidier and an anticancer agent and uses thereof |
08/13/2003 | EP1333846A1 Preparation and xenotransplantation or porcine islets |
08/13/2003 | EP1333845A1 Treatment of t cell disorders |
08/13/2003 | EP1333844A2 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
08/13/2003 | EP1333843A2 Compositions and methods for prolonging survival of chilled platelets |
08/13/2003 | EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation |
08/13/2003 | EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
08/13/2003 | EP1163008B1 Use of trehalose for stabilising a liquid vaccine |
08/13/2003 | EP1152768B1 Treatment of chronic viral infections with m. vaccae |
08/13/2003 | EP1066060B1 Mesenchymal stem cells as immunosuppressants |
08/13/2003 | EP0768886B1 Endothelial lining effects and treatment of vasospastic disorders |
08/13/2003 | EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
08/13/2003 | CN1436241A Sphingosine kinase and uses thereof |
08/13/2003 | CN1436193A Antitumoral ecteinascidin derivs |
08/13/2003 | CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity |
08/13/2003 | CN1436072A Composition, kits, and methods for promoting defined health benefits |
08/13/2003 | CN1435252A Ant powder dietetic preparation as broad-spectrum immunity strengthening agent and preparing method thereof |
08/13/2003 | CN1435232A ÔÇ£KesaiÔÇØ potus for treating malignant tumor |
08/13/2003 | CN1435202A Medicine for treating child diarrhea |
08/13/2003 | CN1435199A Burn film-coating agent |
08/13/2003 | CN1435191A Chinese medicine for bone-knitting and method for preparing same |
08/13/2003 | CN1435190A Meridians-activating pain-alleviating plaster for treating pains of neck, shoulder, waist and leg |
08/13/2003 | CN1435187A Neural stem cell preparation, preparing method thereof and use of same |
08/13/2003 | CN1435186A Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia and apoplexy sequela |
08/13/2003 | CN1435179A Biologic converted ginseng composition and preparing process thereof |
08/13/2003 | CN1435104A Pearl-contg. Yoghurt and producing process thereof |
08/13/2003 | CN1117583C Medicine for treating lumbago |
08/13/2003 | CN1117581C Chinese medicine for treating angina pectonis |
08/13/2003 | CN1117576C Chinese patent for regulating function of liver and spleen |
08/13/2003 | CN1117575C Drug-dropping Chinese patent medicine for improving immunity of human body itself |